That's why I'm saying the pps is cheap as the market hasn't valued them and didn't you value RAC's MC at $500M for just FPI???? We know the stock has always been heavily trade and short since entering the ASX 200 and it has been traded after the excellent clinical trial update for VAXINIA and Azer-Cel. Will it be different this time with a significantly lower O/S and further positive clinical trial update especially from OASIS, we will know in 8-12 months.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)